HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lancet sunscreen study

This article was originally published in The Rose Sheet

Executive Summary

UCal researchers claim use of daily sunscreen is not a "cost-effective public-health measure" in a letter in the Dec. 18/25, 1999 issue of The Lancet. Jeffrey Linder and Jeffrey Tice, Division of General Internal Medicine, University of California at San Francisco, argue that in regions with lower incidences of squamous cell carcinomas - the U.S., for example - daily use of sunscreen by all adults would cost more than full treatment of all cases of SCC. The UCal researchers agree, however, that sunscreen use "during times of high exposure is crucial." The researchers respond to a study published in the Sept. 13 Lancet by Adele Green, Queensland Institute of Medical Research, et al. on use of sunscreen to prevent cutaneous SCC in Australian adults ("The Rose Sheet" Sept. 13, 1999, p. 9)
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS007515

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel